Florent Ginhoux Selected Research

RNA (Ribonucleic Acid)

6/2022	Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19.
1/2022	Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult.
12/2021	Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.
8/2021	Dysregulated hematopoiesis in bone marrow marks severe COVID-19.
1/2021	Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction.
1/2020	Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
1/2020	Excessive Polyamine Generation in Keratinocytes Promotes Self-RNA Sensing by Dendritic Cells in Psoriasis.
1/2019	Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes.
1/2019	Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florent Ginhoux Research Topics

Disease

24	Neoplasms (Cancer) 11/2022 - 01/2002
18	Infections 06/2022 - 04/2011
15	Inflammation (Inflammations) 10/2021 - 12/2012
7	COVID-19 06/2022 - 01/2020
4	Liver Diseases (Liver Disease) 01/2021 - 07/2015
3	Fibrosis (Cirrhosis) 02/2020 - 01/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 01/2017
3	Melanoma (Melanoma, Malignant) 04/2016 - 01/2002
3	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2011 - 11/2006
2	Neuroinflammatory Diseases 01/2022 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 02/2020
2	Obesity 01/2021 - 10/2017
2	Skin Diseases (Skin Disease) 01/2021 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2021 - 09/2013
2	Disease Progression 01/2021 - 05/2015
2	Hypersensitivity (Allergy) 11/2020 - 07/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2020 - 01/2012
2	Malaria 07/2013 - 06/2013
1	Hypoxia (Hypoxemia) 11/2022
1	Cytokine Release Syndrome 06/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Drug Resistant Epilepsy 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Gliosis 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Lymphopenia (Lymphocytopenia) 12/2021
1	Encephalomyelitis (Myeloencephalitis) 10/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 10/2021
1	Chronic Hepatitis B 10/2021
1	Folliculitis (Sycosis) 01/2021
1	Hemoglobinopathies 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Pruritus (Itching) 01/2021
1	Brain Neoplasms (Brain Tumor) 12/2020

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2019
9	AntigensIBA 10/2021 - 07/2013
6	CytokinesIBA 01/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2011
4	LigandsIBA 11/2022 - 01/2017
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 07/2014
4	AntibodiesIBA 12/2021 - 04/2011
4	VaccinesIBA 10/2021 - 07/2011
3	Peptides (Polypeptides)IBA 01/2022 - 12/2017
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 11/2013
2	Granzymes (Granzyme)IBA 11/2022 - 12/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 06/2022 - 01/2020
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2021
2	InterferonsIBA 01/2022 - 10/2021
2	PlasticsIBA 01/2022 - 11/2020
2	Mitogen-Activated Protein KinasesIBA 10/2021 - 10/2016
2	InflammasomesIBA 06/2021 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2021 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2021
2	Poly I-CIBA 01/2021 - 04/2016
2	AllergensIBA 11/2020 - 01/2017
2	Complement System Proteins (Complement)IBA 12/2019 - 01/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019 - 01/2017
2	Imiquimod (Aldara)FDA LinkGeneric 10/2017 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2002
2	flt3 ligand protein (flt3 ligand)IBA 06/2013 - 01/2012
1	ChemokinesIBA 11/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022
1	AlarminsIBA 06/2022
1	AndrogensIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	SmokeIBA 01/2022
1	Immunoglobulin G (IgG)IBA 12/2021
1	Viral RNAIBA 12/2021
1	Prostaglandin D2IBA 10/2021
1	dabrafenibIBA 10/2021
1	CD40 Ligand (CD40L)IBA 10/2021
1	Tryptophan (L-Tryptophan)FDA Link 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2021
1	Gemcitabine FDA Link 06/2021
1	Annexin A1IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	CarcinogensIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Interferon Type IIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Serine Proteases (Serine Protease)IBA 01/2021
1	Celecoxib (Celebrex)FDA Link 01/2021
1	phosphatidylserine receptorIBA 01/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 04/2016
5	Immunotherapy 01/2021 - 01/2002
3	Transplantation 11/2015 - 11/2006
2	Cell Transplantation 01/2021 - 05/2011
2	Injections 01/2017 - 04/2016
1	Castration 01/2022
1	Drug Therapy (Chemotherapy) 01/2021